Jeff Hosry, MD

4.9 (40)

Specialty: Infectious Diseases

Program: Infectious Diseases

Language(s): English

1-888-663-3488

Insurance Coverage Information

Schedule appointment

Participating Trials

Clinical Trial 24083
Incidence and risk factors for invasive fungal infections in patients with chronic graft-versus-host disease following allogeneic bone marrow transplantation.
Condition: Malignant Hematology
Status: Open

If you believe you are eligible for one of these trials or studies, please call
813-745-6100 or toll-free 1-800-679-0775.
Publications
- Hosry J, Wang T, Assaad M, Kamel R, Homsy S, Sleiman E, Glaser A, Mobarakai NK. The Clinical Value of Methicillin-Resistant Staphylococcus aureus Nasal Screening in the Management of Diabetic Foot Infections. Int J Low Extrem Wounds. 2025 Dec.24(4):956-962. Pubmedid: 36113032.
- Yibirin M, Mustafayev K, Hosry J, Pundhir P, Klingen J, Yepez Guevara E, Granwehr BP, Kaseb A, Naing A, Patel S, Shah AY, Skoulidis F, Tawbi HA, Wang L, Miller E, Zhang HC, Zurita-Saavedra A, Torres HA. Immune Checkpoint Inhibitors Suppress Hepatitis C Virus Replication in Infected Patients With Solid Tumors. Am J Gastroenterol. 2023 Sep.118(9):1609-1617. Pubmedid: 37307533. Pmcid: PMC11809494.
- Yibirin M, Hosry J, Yepez Guevara E, Granwehr BP, Jiang Y, Mustafayev K, Angelidakis G, Torres HA. High sustained virologic response rate after 8 weeks of direct-acting antivirals in cancer patients with chronic hepatitis C virus. Eur J Gastroenterol Hepatol. 2022 Oct.34(10):1098-1101. Pubmedid: 36062500.
- MacDougall K, Niazi MRK, Hosry J, Homsy S, Bershadskiy A. The Prognostic Significance of Peripheral Blood Biomarkers in Patients With Advanced Non-Small Cell Lung Cancer Treated With Pembrolizumab: A Clinical Study. Oncology (Williston Park). 2022 Mar.36(3):156-161. Pubmedid: 35298118.
- Assaad M, Hekmat-Joo N, Hosry J, Kassem A, Itani A, Dahabra L, Abou Yassine A, Zaidan J, El Sayegh D. Insulin use in type II diabetic patients: a predictive of mortality in covid-19 infection. Diabetol Metab Syndr. 2022 Jun.14(1):85. Pubmedid: 35725489. Pmcid: PMC9206887.
- Al Moussawi H, Alsheikh M, Kamar K, Awada Z, Hosry J, Deeb L. Beyond Pain Relief: Is Opioids Use Safe in Clostridium difficile Infection?. Gastroenterology Res. 2021 Oct.14(5):275-280. Pubmedid: 34804271. Pmcid: PMC8577597.
- Sleiman E, Hosry J, Caruana L, Schwartz M, Boutros K, Tabet R, Salmane C, Kandov R, Royzman R, Tamburrino F, Lafferty J. Gender-related Disparities of Percutaneous Coronary Interventions in ST-elevation Myocardial Infarction: A Retrospective Chart Review of 500 Patients. Crit Pathw Cardiol. 2021 Jun.20(2):63-66. Pubmedid: 32769483.
- Elfiky A, Alsheikh M, Hosry J, Aqsa A, Yassine AA, Deeb L. Is the Use of Proton Pump Inhibitors a Predisposing Factor for Pyogenic Liver Abscesses?. Gastroenterology Res. 2021 Jun.14(3):184-189. Pubmedid: 34267834. Pmcid: PMC8256900.
- Pritchard H, Jandhyala D, Hosry J, Angelidakis G, Torres HA. Salvage therapy in cancer patients with hepatitis C without sustained virologic response after direct-acting antivirals-A prospective study. JGH Open. 2020 Jun.4(3):541-544. Pubmedid: 32514467. Pmcid: PMC7273696.
- Hosry J, Miranda RN, Samaniego F, Angelidakis G, Torres HA. Clinicopathologic characteristics of follicular lymphoma in hepatitis C virus-infected patients. Hematol Oncol. 2020 Aug.38(3):301-308. Pubmedid: 32196714.
- Torres HA, Economides MP, Angelidakis G, Hosry J, Kyvernitakis A, Mahale P, Jiang Y, Miller E, Blechacz B, Naing A, Samaniego F, Kaseb A, Raad II, Granwehr BP. Sofosbuvir-Based Therapy in Hepatitis C Virus-Infected Cancer Patients: A Prospective Observational Study. Am J Gastroenterol. 2019 Feb.114(2):250-257. Pubmedid: 30410039.
- Angelidakis G, Hwang JP, Dandachi D, Economides MP, Hosry J, Granwehr BP, Torres HA. Universal screening for hepatitis C: A needed approach in patients with haematologic malignancies. J Viral Hepat. 2018 Sep.25(9):1102-1104. Pubmedid: 29660201.
- Hosry J, Angelidakis G, Kaseb A, Jiang Y, Torres HA. Inhibition of Hepatitis C Virus Replication Induced by Chemotherapy: A Prospective Observational Study. Clin Infect Dis. 2018 Oct.67(10):1635-1636. Pubmedid: 30124786. Pmcid: PMC6206115.
- Hosry J, Miranda RN, Samaniego F, Economides MP, Torres HA. Clinicopathologic characteristics and outcomes of transformed diffuse large B-cell lymphoma in hepatitis C virus-infected patients. Int J Cancer. 2018 Mar.142(5):940-948. Pubmedid: 29047108. Pmcid: PMC5760439.
- Economides MP, Amit M, Mahale PS, Hosry JJ, Jiang Y, Bharadwaj U, Sturgis EM, Torres HA. Impact of chronic hepatitis C virus infection on the survival of patients with oropharyngeal cancer. Cancer. 2018 Mar.124(5):960-965. Pubmedid: 29149493. Pmcid: PMC5821521.
- Ferrufino-Schmidt MC, Medeiros LJ, Liu H, Clemens MW, Hunt KK, Laurent C, Lofts J, Amin MB, Ming Chai S, Morine A, Di Napoli A, Dogan A, Parkash V, Bhagat G, Tritz D, Quesada AE, Pina-Oviedo S, Hu Q, Garcia-Gomez FJ, Jose Borrero J, Horna P, Thakral B, Narbaitz M, Hughes RC, Yang LJ, Fromm JR, Wu D, Zhang D, Sohani AR, Hunt J, Vadlamani IU, Morgan EA, Ferry JA, Szigeti R, C Tardio J, Granados R, Dertinger S, Offner FA, Pircher A, Hosry J, Young KH, Miranda RN. Clinicopathologic Features and Prognostic Impact of Lymph Node Involvement in Patients With Breast Implant-associated Anaplastic Large Cell Lymphoma. Am J Surg Pathol. 2018 Mar.42(3):293-305. Pubmedid: 29194092. Pmcid: PMC7500854.
- Torres HA, Hosry J, Mahale P, Economides MP, Jiang Y, Lok AS. Hepatitis C virus reactivation in patients receiving cancer treatment: A prospective observational study. Hepatology. 2018 Jan.67(1):36-47. Pubmedid: 28653760. Pmcid: PMC5739995.
- Economides MP, Mahale P, Turturro F, Hosry J, Samaniego F, Granwehr BP, Torres HA. Development of non-Hodgkin lymphoma as a second primary cancer in hepatitis C virus-infected patients with a different primary malignancy. Leuk Lymphoma. 2017 Feb.58(2):485-488. Pubmedid: 27348218.
- Economides MP, Mahale P, Kyvernitakis A, Turturro F, Kantarjian H, Naing A, Hosry J, Shigle TL, Kaseb A, Torres HA. Concomitant use of direct-acting antivirals and chemotherapy in hepatitis C virus-infected patients with cancer. Aliment Pharmacol Ther. 2016 Dec.44(11-12):1235-1241. Pubmedid: 27730654. Pmcid: PMC5123740.
- Hosry J, Mahale P, Turturro F, Miranda RN, Economides MP, Granwehr BP, Torres HA. Antiviral therapy improves overall survival in hepatitis C virus-infected patients who develop diffuse large B-cell lymphoma. Int J Cancer. 2016 Dec.139(11):2519-2528. Pubmedid: 27501007. Pmcid: PMC5028297.
- Kyvernitakis A, Mahale P, Popat UR, Jiang Y, Hosry J, Champlin RE, Torres HA. Hepatitis C Virus Infection in Patients Undergoing Hematopoietic Cell Transplantation in the Era of Direct-Acting Antiviral Agents. Biol Blood Marrow Tr. 2016 Apr.22(4):717-722. Pubmedid: 26712592. Pmcid: PMC4828726.
Patient Comments
Comments are gathered from specific care provider-related questions from our Patient Satisfaction Survey . The comments are submitted by patients and reflect their views and opinions. Patients are de-identified for confidentiality and patient privacy.

Learn more about our patient comments
Overall Satisfaction

4.9

40 patients rated this provider

The Provider Rating is an average of all responses to specific care provider-related questions from our nationally-recognized Press Ganey Patient Satisfaction Survey. Responses are measured on a scale of 1 to 5 with 5 being the best score.

Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.
Learn more about our patient satisfaction survey

Comments

Comments are gathered from specific care provider-related questions from our Patient Satisfaction Survey . The comments are submitted by patients and reflect their views and opinions. Patients are de-identified for confidentiality and patient privacy.

Learn more about our patient comments

We post both positive and negative comments from the surveys. We do not post comments that are libelous, slanderous, profane, irrelevant or otherwise inappropriate or may risk the privacy of our patients. A “[…]” in the comments below indicates de-identified patient information or comments that are unrelated to the patient’s experience with the visit to the provider, such as comments related to another provider, about the survey itself, or otherwise completely off-topic.

Provider Ratings and comments are gathered from our nationally-recognized Press Ganey Patient Satisfaction Survey. If a provider does not have ratings or comments listed it can be for several reasons, including:
- The provider has not yet received the minimum number of patient satisfaction surveys to be eligible for display. We require a minimum of 10 surveys before we post results to ensure that the rating is statistically reliable and a true reflection of patient satisfaction.
- He or she may be a researcher or other type of provider that does not see patients.
- The provider practices in a specialty or office that does not use the specified surveys currently used for these ratings.
Learn more about our patient satisfaction survey, ratings and comments

Cancer Type

Doctor or Provider Type

Location

Gender

Language

Specialty

Department or Program

Jeff Hosry, MD

Participating Trials

Publications

Patient Comments

Comments

Find a Doctor

Cambiar el idioma